prednisone has been researched along with Central Nervous System Neoplasm in 123 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "During the Rituximab era, high dose intravenous methotrexate (HD) and intrathecal methotrexate (IT) are recommended prophylaxis in preventing central nervous system (CNS) relapse of diffuse large B-cell lymphoma (DLBCL) patients." | 9.22 | Prophylaxis strategies containing high dose intravenous methotrexate on preventing CNS relapse for patients with diffuse large B-cell lymphoma at intermediate to high risk: A study based on 12 cohorts in the rituximab era. ( Liu, B; Shi, X; Wang, Z; Xie, X; Xu, D; Zhang, N, 2022) |
| "Although methotrexate (MTX) is the most widely used therapy for central nervous system (CNS) prophylaxis in patients with diffuse large B-cell lymphoma (DLBCL), the optimal regimen remains unclear." | 8.02 | Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse. ( Batlevi, CL; Bobillo, S; Caron, PC; Dogan, A; Ghione, P; Hamilton, A; Hamlin, PA; Horwitz, SM; Joffe, E; Kumar, A; Matasar, MJ; Mondello, P; Moskowitz, A; Noy, A; Owens, CN; Palomba, ML; Sermer, D; Seshan, VE; Straus, D; von Keudell, G; Younes, A; Zelenetz, AD, 2021) |
| "This study evaluated the efficacy of central nervous system (CNS) prophylaxis using intrathecal methotrexate (IT-MTX) in patients with diffuse large B-cell lymphoma (DLBCL)." | 7.81 | Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone. ( Fujimaki, K; Hagihara, M; Hashimoto, C; Ishibashi, D; Ishigatsubo, Y; Ishii, Y; Ishiyama, Y; Kishimoto, K; Koyama, S; Motomura, S; Numata, A; Ohshima, R; Sakai, R; Tachibana, T; Taguchi, J; Takahashi, H; Takasaki, H; Takemura, S; Tomita, N; Watanabe, R, 2015) |
| "The activity of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of primary central nervous system lymphoma (PCNSL) prior to radiotherapy was studied in six patients." | 7.69 | Cyclophosphamide, doxorubicin, vincristine, and prednisone for primary central nervous system lymphoma: short-duration response and multifocal intracerebral recurrence preceding radiotherapy. ( Boyko, OB; Brizel, DM; Brown, MT; Burger, PC; Gockerman, JP; Halperin, EC; Lachance, DH; Schold, SC, 1994) |
| "Although prophylaxis against CNS recurrence with either intrathecal or intravenous methotrexate is commonly used for such patients, to the authors' knowledge, there is no standard of care." | 5.36 | Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma. ( Abramson, JS; Barnes, JA; Hammerman, P; Hellmann, M; Hochberg, EP; Muzikansky, A; Takvorian, T; Toomey, C, 2010) |
| "During the Rituximab era, high dose intravenous methotrexate (HD) and intrathecal methotrexate (IT) are recommended prophylaxis in preventing central nervous system (CNS) relapse of diffuse large B-cell lymphoma (DLBCL) patients." | 5.22 | Prophylaxis strategies containing high dose intravenous methotrexate on preventing CNS relapse for patients with diffuse large B-cell lymphoma at intermediate to high risk: A study based on 12 cohorts in the rituximab era. ( Liu, B; Shi, X; Wang, Z; Xie, X; Xu, D; Zhang, N, 2022) |
| "Central nervous system (CNS) prophylaxis for diffuse large B-cell lymphoma (DLBCL) is controversial with even less evidence in the era of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy." | 4.88 | Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature. ( Berinstein, N; Buckstein, R; Cheung, MC; Guirguis, HR; Imrie, KR; Mahrous, M; Piliotis, E; Zhang, L, 2012) |
| "Prophylactic high-dose methotrexate (HD-MTX) is often used for diffuse large B-cell lymphoma (DLBCL) patients at high risk of central nervous system (CNS) relapse, despite limited evidence demonstrating efficacy or the optimal delivery method." | 4.12 | Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients. ( Agbetiafa, K; Ahearne, M; Barlow, BR; Calimeri, T; Cheah, CY; Choquet, S; Clavert, A; Cwynarski, K; Durot, E; Ebsworth, TJ; El Galaly, TC; Elliot, J; Eyre, TA; Fernandez, R; Ferreri, AJM; Forgeard, N; Fox, CP; Gounder, P; Guidetti, A; Hamad, N; Htut, TW; Khwaja, J; Kirkwood, AA; Ku, M; Lebras, L; Lees, C; Lewis, KL; Liu, Q; Lombion, N; Lopez-Garcia, A; Manos, K; Martinez-Calle, N; McIlroy, G; McKay, P; Miall, F; Moles-Moreau, MP; Narkhede, M; O'Mahony, D; Preston, G; Renaud, L; Ricard, L; Roulin, L; Rusconi, C; Santarsieri, A; Schorb, E; Scott, H; Shah, N; Smith, J; Soussain, C; Strüßmann, T; Tchernonog, E; Vassallo, F; Wilson, MR; Wong Doo, N; Zayac, AS; Øvlisen, AK, 2022) |
| "Although methotrexate (MTX) is the most widely used therapy for central nervous system (CNS) prophylaxis in patients with diffuse large B-cell lymphoma (DLBCL), the optimal regimen remains unclear." | 4.02 | Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse. ( Batlevi, CL; Bobillo, S; Caron, PC; Dogan, A; Ghione, P; Hamilton, A; Hamlin, PA; Horwitz, SM; Joffe, E; Kumar, A; Matasar, MJ; Mondello, P; Moskowitz, A; Noy, A; Owens, CN; Palomba, ML; Sermer, D; Seshan, VE; Straus, D; von Keudell, G; Younes, A; Zelenetz, AD, 2021) |
| "This study evaluated the efficacy of central nervous system (CNS) prophylaxis using intrathecal methotrexate (IT-MTX) in patients with diffuse large B-cell lymphoma (DLBCL)." | 3.81 | Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone. ( Fujimaki, K; Hagihara, M; Hashimoto, C; Ishibashi, D; Ishigatsubo, Y; Ishii, Y; Ishiyama, Y; Kishimoto, K; Koyama, S; Motomura, S; Numata, A; Ohshima, R; Sakai, R; Tachibana, T; Taguchi, J; Takahashi, H; Takasaki, H; Takemura, S; Tomita, N; Watanabe, R, 2015) |
| "The addition of rituximab to CHOP (R-CHOP; CHOP, cyclophosphamide, doxorubicin, vincristine, and prednisone) chemotherapy improves outcome in patients with diffuse large B-cell lymphoma (DLBCL)." | 3.76 | Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy. ( Connors, JM; Gascoyne, RD; Savage, KJ; Sehn, LH; Shenkier, TN; Villa, D, 2010) |
| " We retrospectively studied the risk factors for CNS involvement in patients with diffuse large B-cell lymphoma (DLBCL) treated by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or rituximab (R) -CHOP chemotherapy." | 3.76 | Central nervous system involvement in diffuse large B-cell lymphoma. ( Hashimoto, C; Hattori, Y; Hyo, R; Ishigatsubo, Y; Motomura, S; Nakajima, Y; Tomita, N; Watanabe, R; Yamamoto, W, 2010) |
| "The activity of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of primary central nervous system lymphoma (PCNSL) prior to radiotherapy was studied in six patients." | 3.69 | Cyclophosphamide, doxorubicin, vincristine, and prednisone for primary central nervous system lymphoma: short-duration response and multifocal intracerebral recurrence preceding radiotherapy. ( Boyko, OB; Brizel, DM; Brown, MT; Burger, PC; Gockerman, JP; Halperin, EC; Lachance, DH; Schold, SC, 1994) |
| "Children and adolescents with Burkitt Lymphoma (BL) and combined central nervous system (CNS) and bone marrow involvement still have a poor prognosis with chemotherapy alone." | 2.79 | Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report. ( Anderson, JR; Barth, M; Cairo, MS; Frazer, JK; Galardy, P; Goldman, S; Gross, TG; Harrison, L; Perkins, SL; Sanger, W; Shiramizu, B; Smith, L; Weinstein, H, 2014) |
| "Treatment of childhood relapsed acute lymphoblastic leukemia (ALL) remains a significant challenge." | 2.73 | Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected]. ( Borowitz, MJ; Camitta, BM; Carroll, WL; Devidas, M; Gaynon, PS; Hunger, SP; Linda, SB; Raetz, EA; Winick, NJ, 2008) |
| "To improve the outcome of children with acute lymphoblastic leukemia (ALL) treated at the National Cancer Institute, Bogota, Colombia, a protocol based on the BFM-90 (Berlin, Frankfurt, Munster study) and the LSA2L2 regimens was implemented in the year 1993." | 2.73 | The impact of acute lymphoblastic leukemia treatment on central nervous system results in Bogota, Colombia. ( Buendia, MT; Guevara, G; Lozano, JM; Saavedra, C; Suarez, GE, 2008) |
| "He was diagnosed with stage II Hodgkin's lymphoma at the age of 15, and we considered the possibility of newly emerged CNS lymphoma occurring in the immunosuppressive condition after the treatment of Hodgkin's lymphoma." | 2.52 | Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) after treatment for Hodgkin's lymphoma. ( Hirose, S; Mashima, K; Mori, T; Okamoto, S; Shimizu, T; Suzuki, N; Suzuki, S; Yamada, S, 2015) |
| "Initial spinal cord compression (ISCC) in B-cell non-Hodgkin lymphoma (NHL) is rarely present at diagnosis." | 1.42 | Management and prognosis of 66 patients with B-cell non-Hodgkin lymphoma presenting with initial spinal cord compression: a French retrospective multicenter study. ( Amorim, S; Brice, P; Brière, J; Coiffier, B; de Kerviler, E; Dupuis, J; Filliatre, L; Fleury, I; Mazari, MA; Mounier, N; Thieblemont, C; Tilly, H, 2015) |
| "Given the overall low rate of CNS recurrence and lack of prophylaxis-associated survival benefit, the current data called into question the practice of CNS prophylaxis in the rituximab era." | 1.38 | Lack of benefit of central nervous system prophylaxis for diffuse large B-cell lymphoma in the rituximab era: findings from a large national database. ( Abel, GA; Crosby, AL; Czuczman, MS; Friedberg, JW; Gordon, LI; Kumar, A; LaCasce, AS; Lepisto, E; Millenson, M; Nademanee, A; Niland, J; Rodriguez, MA; Vanderplas, A; Zelenetz, AD, 2012) |
| "There were no CNS recurrences in the three patients who received CNS prophylaxis." | 1.37 | Bulky disease has an impact on outcomes in primary diffuse large B-cell lymphoma of the breast: a retrospective analysis at a single institution. ( Fukuhara, S; Kim, SW; Kobayashi, Y; Maeshima, AM; Maruyama, D; Matsuno, Y; Mori, M; Munakata, W; Taniguchi, H; Tanosaki, R; Tobinai, K; Watanabe, T, 2011) |
| "A 58-year-old Caucasian woman with multiple myeloma developed subacute vision loss bilaterally and was found to have plasma cells in her cerebrospinal fluid." | 1.37 | Central nervous system myelomatosis with optic neuropathy and intramedullary spinal cord compression responding to radiation therapy. ( Alsharif, M; Jenrette, JM; Riley, JM; Russo, JK; Shipp, A, 2011) |
| "Although prophylaxis against CNS recurrence with either intrathecal or intravenous methotrexate is commonly used for such patients, to the authors' knowledge, there is no standard of care." | 1.36 | Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma. ( Abramson, JS; Barnes, JA; Hammerman, P; Hellmann, M; Hochberg, EP; Muzikansky, A; Takvorian, T; Toomey, C, 2010) |
| "Sarcoidosis is uncommon in children." | 1.34 | Isolated neurosarcoidosis presenting as headache and multiple brain and spinal cord lesions mimicking central nervous system metastases. ( Boue, DR; Henwood, MJ; Lo, WD; Rusin, JA; Tsao, CY, 2007) |
| "In a random HIV-seropositive population, malignant lymphomas were diagnosed in 31 patients, of whom 24 (77%) had non-Hodgkin lymphoma (NHL) and 7 (23%) Hodgkin lymphoma (HL)." | 1.28 | Malignant lymphomas in HIV-seropositive patients. Frequency, features, and prognosis. Report on 31 cases. ( Cervos-Navarro, J; Dienemann, D; Jautzke, G; Langford, A; Pohle, HD; Ruf, B; Schürmann, D; Stein, H, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 17 (13.82) | 18.2507 |
| 2000's | 28 (22.76) | 29.6817 |
| 2010's | 62 (50.41) | 24.3611 |
| 2020's | 16 (13.01) | 2.80 |
| Authors | Studies |
|---|---|
| Ho, G | 1 |
| Tan, C | 1 |
| de Mel, S | 1 |
| Poon, L | 1 |
| Chan, EHL | 1 |
| Lee, J | 1 |
| Liu, X | 1 |
| Chng, WJ | 1 |
| Chee, YL | 1 |
| Soon, YY | 1 |
| Jeyasekharan, AD | 1 |
| Reiss, SN | 1 |
| Yerram, P | 1 |
| Modelevsky, L | 1 |
| Grommes, C | 1 |
| Wilson, MR | 1 |
| Eyre, TA | 3 |
| Kirkwood, AA | 3 |
| Wong Doo, N | 1 |
| Soussain, C | 1 |
| Choquet, S | 1 |
| Martinez-Calle, N | 2 |
| Preston, G | 1 |
| Ahearne, M | 1 |
| Schorb, E | 1 |
| Moles-Moreau, MP | 1 |
| Ku, M | 1 |
| Rusconi, C | 1 |
| Khwaja, J | 1 |
| Narkhede, M | 1 |
| Lewis, KL | 2 |
| Calimeri, T | 1 |
| Durot, E | 1 |
| Renaud, L | 1 |
| Øvlisen, AK | 1 |
| McIlroy, G | 1 |
| Ebsworth, TJ | 1 |
| Elliot, J | 1 |
| Santarsieri, A | 1 |
| Ricard, L | 1 |
| Shah, N | 2 |
| Liu, Q | 2 |
| Zayac, AS | 1 |
| Vassallo, F | 1 |
| Lebras, L | 1 |
| Roulin, L | 1 |
| Lombion, N | 1 |
| Manos, K | 1 |
| Fernandez, R | 1 |
| Hamad, N | 1 |
| Lopez-Garcia, A | 1 |
| O'Mahony, D | 1 |
| Gounder, P | 1 |
| Forgeard, N | 1 |
| Lees, C | 1 |
| Agbetiafa, K | 1 |
| Strüßmann, T | 1 |
| Htut, TW | 1 |
| Clavert, A | 1 |
| Scott, H | 1 |
| Guidetti, A | 1 |
| Barlow, BR | 1 |
| Tchernonog, E | 1 |
| Smith, J | 1 |
| Miall, F | 1 |
| Fox, CP | 2 |
| Cheah, CY | 4 |
| El Galaly, TC | 1 |
| Ferreri, AJM | 1 |
| Cwynarski, K | 1 |
| McKay, P | 1 |
| Zhang, N | 1 |
| Xu, D | 1 |
| Liu, B | 1 |
| Shi, X | 1 |
| Xie, X | 1 |
| Wang, Z | 1 |
| Lantz, J | 1 |
| Portell, CA | 1 |
| Ayers, EC | 1 |
| Miyazaki, K | 1 |
| Djebbari, F | 1 |
| Collins, GP | 2 |
| Yoon, SE | 1 |
| Kim, WS | 3 |
| Kim, SJ | 3 |
| Oka, S | 1 |
| Ono, K | 1 |
| Nohgawa, M | 1 |
| Kuitunen, H | 1 |
| Kaprio, E | 1 |
| Karihtala, P | 1 |
| Makkonen, V | 1 |
| Kauppila, S | 1 |
| Haapasaari, KM | 1 |
| Kuusisto, M | 1 |
| Jantunen, E | 1 |
| Turpeenniemi-Hujanen, T | 1 |
| Kuittinen, O | 1 |
| Solís-Armenta, R | 1 |
| Cacho-Díaz, B | 1 |
| Gutiérrez-Hernández, O | 1 |
| Candelaria-Hernández, M | 1 |
| Steinhardt, MJ | 1 |
| Krummenast, FC | 1 |
| Rosenwald, A | 1 |
| Gerhard-Hartmann, E | 1 |
| Heidemeier, A | 1 |
| Einsele, H | 1 |
| Topp, MS | 1 |
| Duell, J | 1 |
| Bobillo, S | 1 |
| Joffe, E | 1 |
| Sermer, D | 1 |
| Mondello, P | 1 |
| Ghione, P | 1 |
| Caron, PC | 1 |
| Hamilton, A | 1 |
| Hamlin, PA | 1 |
| Horwitz, SM | 1 |
| Kumar, A | 2 |
| Matasar, MJ | 1 |
| Batlevi, CL | 1 |
| Moskowitz, A | 1 |
| Noy, A | 1 |
| Owens, CN | 1 |
| Palomba, ML | 1 |
| Straus, D | 1 |
| von Keudell, G | 1 |
| Dogan, A | 1 |
| Zelenetz, AD | 3 |
| Seshan, VE | 1 |
| Younes, A | 1 |
| Shimada, K | 2 |
| Kiyoi, H | 1 |
| Winick, N | 1 |
| Devidas, M | 3 |
| Chen, S | 1 |
| Maloney, K | 1 |
| Larsen, E | 1 |
| Mattano, L | 1 |
| Borowitz, MJ | 3 |
| Carroll, A | 1 |
| Gastier-Foster, JM | 1 |
| Heerema, NA | 1 |
| Willman, C | 1 |
| Wood, B | 1 |
| Loh, ML | 1 |
| Raetz, E | 1 |
| Hunger, SP | 2 |
| Carroll, WL | 2 |
| Tomita, N | 3 |
| Yokoyama, M | 1 |
| Yamamoto, W | 2 |
| Watanabe, R | 3 |
| Shimazu, Y | 1 |
| Masaki, Y | 1 |
| Tsunoda, S | 1 |
| Hashimoto, C | 3 |
| Murayama, K | 1 |
| Yano, T | 1 |
| Okamoto, R | 1 |
| Kikuchi, A | 1 |
| Tamura, K | 1 |
| Sato, K | 1 |
| Sunami, K | 1 |
| Shibayama, H | 1 |
| Takimoto, R | 1 |
| Ohshima, R | 2 |
| Takahashi, H | 6 |
| Moriuchi, Y | 1 |
| Kinoshita, T | 1 |
| Yamamoto, M | 1 |
| Numata, A | 2 |
| Nakajima, H | 1 |
| Miura, I | 1 |
| Takeuchi, K | 1 |
| Malecek, MK | 1 |
| Petrich, AM | 2 |
| Rozell, S | 1 |
| Chu, B | 1 |
| Trifilio, S | 1 |
| Galanina, N | 1 |
| Maurer, M | 1 |
| Farooq, U | 1 |
| Link, BK | 1 |
| Nowakowski, GS | 2 |
| Nabhan, C | 2 |
| Ayed, AO | 2 |
| Kimura, Y | 1 |
| Takeuchi, M | 1 |
| Matsue, K | 1 |
| Gleeson, M | 1 |
| Counsell, N | 1 |
| Cunningham, D | 1 |
| Chadwick, N | 1 |
| Lawrie, A | 1 |
| Hawkes, EA | 1 |
| McMillan, A | 2 |
| Ardeshna, KM | 1 |
| Jack, A | 1 |
| Smith, P | 1 |
| Mouncey, P | 1 |
| Pocock, C | 1 |
| Radford, JA | 1 |
| Davies, J | 1 |
| Turner, D | 1 |
| Kruger, A | 1 |
| Johnson, P | 1 |
| Gambell, J | 1 |
| Linch, D | 1 |
| Wang, H | 1 |
| Wang, M | 1 |
| Wei, J | 1 |
| Wang, L | 1 |
| Mao, L | 1 |
| Jin, J | 1 |
| Hall, KH | 1 |
| Panjic, EH | 1 |
| Valla, K | 1 |
| Flowers, CR | 1 |
| Cohen, JB | 1 |
| Chiappella, A | 2 |
| Pederson, L | 1 |
| Laplant, BR | 1 |
| Congiu, AG | 1 |
| Gaidano, G | 1 |
| Spina, M | 1 |
| Re, A | 1 |
| Cavallo, F | 1 |
| Musuraca, G | 1 |
| Macon, WR | 1 |
| Witzig, T | 1 |
| Vitolo, U | 2 |
| LaRue, MK | 1 |
| Taylor, AR | 1 |
| Back, AR | 1 |
| Lindley, SE | 1 |
| Boudreaux, BL | 1 |
| Almond, GT | 1 |
| Shores, A | 1 |
| Brawner, WR | 1 |
| Smith, AN | 1 |
| Kansara, R | 3 |
| Thieblemont, C | 2 |
| Bernard, S | 1 |
| Meignan, M | 1 |
| Molina, T | 2 |
| Goldschmidt, N | 1 |
| Horowitz, NA | 1 |
| Heffes, V | 1 |
| Darawshy, F | 1 |
| Mashiach, T | 1 |
| Shaulov, A | 1 |
| Gatt, ME | 1 |
| Dann, EJ | 1 |
| Jordan, B | 1 |
| Zierz, S | 1 |
| Weber, T | 1 |
| Jordan, K | 1 |
| Yamashita, A | 1 |
| Tokuda, M | 1 |
| Matsuo, M | 1 |
| Irie, J | 1 |
| Tateishi, Y | 1 |
| Mutsukura, K | 1 |
| Wolf, J | 1 |
| Hildyard, C | 1 |
| Mercer, C | 1 |
| Plaschkes, H | 1 |
| Griffith, J | 1 |
| Fields, P | 1 |
| Gunawan, A | 1 |
| Oliver, R | 1 |
| Booth, S | 1 |
| Bishton, M | 1 |
| Hatton, CSR | 1 |
| Zhang, J | 1 |
| Chen, B | 1 |
| Xu, X | 1 |
| Deng, L | 1 |
| Song, Y | 1 |
| Zhu, J | 1 |
| Zheng, W | 1 |
| Wang, X | 1 |
| Xie, Y | 1 |
| Lin, N | 1 |
| Tu, M | 1 |
| Ping, L | 1 |
| Ying, Z | 1 |
| Liu, W | 1 |
| Zhang, C | 1 |
| Ghose, A | 1 |
| Kundu, R | 1 |
| Latif, T | 1 |
| Hentrich, M | 1 |
| Hoffmann, C | 1 |
| Mosthaf, F | 1 |
| Müller, M | 1 |
| Siehl, J | 1 |
| Wyen, C | 1 |
| Hensel, M | 1 |
| Takasaki, H | 1 |
| Ishiyama, Y | 1 |
| Kishimoto, K | 1 |
| Ishibashi, D | 1 |
| Koyama, S | 1 |
| Ishii, Y | 1 |
| Tachibana, T | 1 |
| Hagihara, M | 1 |
| Takemura, S | 1 |
| Taguchi, J | 1 |
| Fujimaki, K | 1 |
| Sakai, R | 1 |
| Motomura, S | 2 |
| Ishigatsubo, Y | 2 |
| Goldman, S | 1 |
| Smith, L | 1 |
| Galardy, P | 1 |
| Perkins, SL | 1 |
| Frazer, JK | 1 |
| Sanger, W | 1 |
| Anderson, JR | 1 |
| Gross, TG | 1 |
| Weinstein, H | 1 |
| Harrison, L | 1 |
| Shiramizu, B | 1 |
| Barth, M | 1 |
| Cairo, MS | 2 |
| Herbert, KE | 1 |
| O'Rourke, K | 1 |
| Kennedy, GA | 1 |
| George, A | 1 |
| Fedele, PL | 1 |
| Gilbertson, M | 1 |
| Tan, SY | 1 |
| Ritchie, DS | 1 |
| Opat, SS | 1 |
| Prince, HM | 2 |
| Dickinson, M | 2 |
| Burbury, K | 1 |
| Wolf, M | 2 |
| Januszewicz, EH | 1 |
| Tam, CS | 1 |
| Westerman, DA | 1 |
| Carney, DA | 1 |
| Harrison, SJ | 1 |
| Seymour, JF | 2 |
| Ichikawa, K | 1 |
| Noguchi, M | 1 |
| Koike, M | 1 |
| Aritaka, N | 1 |
| Sekiguchi, Y | 1 |
| Sunami, Y | 1 |
| Tsutsui, M | 1 |
| Hosone, M | 1 |
| Hirano, T | 1 |
| Gotoh, A | 1 |
| Komatsu, N | 1 |
| Ferreri, AJ | 4 |
| Bruno-Ventre, M | 1 |
| Donadoni, G | 1 |
| Ponzoni, M | 1 |
| Citterio, G | 1 |
| Foppoli, M | 1 |
| Vignati, A | 1 |
| Scarfò, L | 1 |
| Sassone, M | 1 |
| Govi, S | 1 |
| Caligaris-Cappio, F | 1 |
| Fleury, I | 1 |
| Amorim, S | 1 |
| Mounier, N | 1 |
| Coiffier, B | 3 |
| Dupuis, J | 1 |
| Tilly, H | 3 |
| Mazari, MA | 1 |
| Filliatre, L | 1 |
| Brière, J | 1 |
| Brice, P | 1 |
| de Kerviler, E | 1 |
| Ellin, F | 1 |
| Landström, J | 1 |
| Jerkeman, M | 2 |
| Relander, T | 1 |
| Rabah, F | 1 |
| Elmanzalawy, A | 1 |
| Bhuyan, D | 1 |
| El-Banna, N | 1 |
| Beshlawi, I | 1 |
| Mashima, K | 1 |
| Suzuki, S | 1 |
| Mori, T | 1 |
| Shimizu, T | 1 |
| Yamada, S | 1 |
| Hirose, S | 1 |
| Okamoto, S | 1 |
| Suzuki, N | 1 |
| Wang, Y | 1 |
| Guo, S | 1 |
| Landsburg, DJ | 1 |
| Abramson, JS | 2 |
| Sohani, AR | 1 |
| Press, O | 1 |
| Cassaday, R | 1 |
| Chavez, JC | 1 |
| Song, K | 1 |
| Gandhi, M | 1 |
| Fenske, TS | 1 |
| Jaso, J | 1 |
| Medeiros, LJ | 2 |
| Yang, DT | 1 |
| Ribrag, V | 1 |
| Koscielny, S | 1 |
| Bosq, J | 1 |
| Leguay, T | 1 |
| Casasnovas, O | 1 |
| Fornecker, LM | 1 |
| Recher, C | 2 |
| Ghesquieres, H | 1 |
| Morschhauser, F | 1 |
| Girault, S | 1 |
| Le Gouill, S | 1 |
| Ojeda-Uribe, M | 1 |
| Mariette, C | 1 |
| Cornillon, J | 1 |
| Cartron, G | 1 |
| Verge, V | 1 |
| Chassagne-Clément, C | 1 |
| Dombret, H | 1 |
| Lamy, T | 1 |
| Salles, G | 1 |
| Turno-Kręcicka, A | 1 |
| Tomczyk-Socha, M | 1 |
| Zimny, A | 1 |
| Schmitz, N | 2 |
| Zeynalova, S | 2 |
| Nickelsen, M | 1 |
| Villa, D | 5 |
| Sehn, LH | 5 |
| Glass, B | 2 |
| Scott, DW | 2 |
| Gascoyne, RD | 5 |
| Connors, JM | 6 |
| Ziepert, M | 1 |
| Pfreundschuh, M | 2 |
| Loeffler, M | 2 |
| Savage, KJ | 5 |
| Gerrie, AS | 2 |
| Klasa, R | 3 |
| Shenkier, T | 2 |
| Slack, GW | 2 |
| Chihara, D | 1 |
| Fowler, NH | 1 |
| Oki, Y | 1 |
| Fanale, MA | 1 |
| Fayad, LE | 1 |
| Westin, JR | 1 |
| Hagemeister, FB | 2 |
| Chan, KL | 1 |
| van der Weyden, C | 1 |
| Khoo, C | 1 |
| Lade, S | 1 |
| Blombery, P | 1 |
| Westerman, D | 1 |
| Khot, A | 1 |
| Melo, B | 1 |
| Johnstone, RW | 1 |
| Cai, QQ | 1 |
| Hu, LY | 1 |
| Geng, QR | 1 |
| Chen, J | 3 |
| Lu, ZH | 1 |
| Rao, HL | 1 |
| Jiang, WQ | 1 |
| Huang, HQ | 1 |
| Lin, TY | 1 |
| Xia, ZJ | 1 |
| Hong, JS | 1 |
| Chang, MH | 1 |
| Kim, JA | 1 |
| Kwak, JY | 1 |
| Kim, JS | 1 |
| Yoon, DH | 1 |
| Lee, WS | 1 |
| Do, YR | 1 |
| Kang, HJ | 2 |
| Eom, HS | 1 |
| Park, Y | 1 |
| Won, JH | 1 |
| Mun, YC | 1 |
| Kim, HJ | 1 |
| Kwon, JH | 1 |
| Kong, JH | 1 |
| Oh, SY | 1 |
| Lee, S | 1 |
| Bae, SH | 1 |
| Yang, DH | 1 |
| Jun, HJ | 1 |
| Kim, YS | 1 |
| Yun, HJ | 1 |
| Lee, SI | 1 |
| Kim, MK | 1 |
| Park, EK | 1 |
| Suh, C | 1 |
| Kridel, R | 1 |
| Telio, D | 1 |
| Tan, K | 1 |
| El-Galaly, TC | 1 |
| Michaelsen, TY | 1 |
| Hutchings, M | 1 |
| Mikhaeel, NG | 1 |
| Barrington, S | 1 |
| Hansen, JW | 1 |
| Smith, D | 1 |
| Rady, K | 1 |
| Mylam, KJ | 1 |
| Larsen, TS | 1 |
| Holmberg, S | 1 |
| Juul, MB | 1 |
| Cordua, S | 1 |
| Clausen, MR | 1 |
| Jensen, KB | 1 |
| Johnsen, HE | 1 |
| de Nully Brown, P | 1 |
| Bøgsted, M | 1 |
| Nijland, M | 1 |
| Jansen, A | 1 |
| Doorduijn, JK | 1 |
| Enting, RH | 1 |
| Bromberg, JEC | 1 |
| Kluin-Nelemans, HC | 1 |
| Chiang, LY | 1 |
| Crawford, JR | 1 |
| Kuo, DJ | 1 |
| Zucca, E | 2 |
| Raetz, EA | 1 |
| Linda, SB | 2 |
| Winick, NJ | 1 |
| Camitta, BM | 2 |
| Gaynon, PS | 1 |
| Buendia, MT | 1 |
| Lozano, JM | 1 |
| Suarez, GE | 1 |
| Saavedra, C | 1 |
| Guevara, G | 1 |
| Conrad, AL | 1 |
| Go, RS | 1 |
| Iványi, JL | 1 |
| Marton, E | 1 |
| Plander, M | 1 |
| Gyánó, G | 1 |
| Czumbil, L | 1 |
| Tóth, C | 1 |
| Shenkier, TN | 2 |
| Hattori, Y | 1 |
| Nakajima, Y | 1 |
| Hyo, R | 1 |
| Hellmann, M | 1 |
| Barnes, JA | 1 |
| Hammerman, P | 1 |
| Toomey, C | 1 |
| Takvorian, T | 1 |
| Muzikansky, A | 1 |
| Hochberg, EP | 1 |
| Canova, F | 1 |
| Marino, D | 1 |
| Trentin, C | 1 |
| Soldà, C | 1 |
| Ghiotto, C | 1 |
| Aversa, SM | 1 |
| Yi, JH | 1 |
| Kim, JH | 1 |
| Baek, KK | 1 |
| Lim, T | 1 |
| Lee, DJ | 1 |
| Ahn, YC | 1 |
| Kim, K | 1 |
| Ko, YH | 1 |
| Tai, WM | 1 |
| Chung, J | 1 |
| Tang, PL | 1 |
| Koo, YX | 1 |
| Hou, X | 1 |
| Tay, KW | 1 |
| Quek, R | 1 |
| Tao, M | 1 |
| Lim, ST | 1 |
| Renard, M | 1 |
| Suciu, S | 1 |
| Bertrand, Y | 1 |
| Uyttebroeck, A | 1 |
| Ferster, A | 1 |
| van der Werff Ten Bosch, J | 1 |
| Mazingue, F | 1 |
| Plouvier, E | 1 |
| Robert, A | 1 |
| Boutard, P | 1 |
| Millot, F | 1 |
| Munzer, M | 1 |
| Mechinaud, F | 1 |
| Lescoeur, B | 1 |
| Baila, L | 1 |
| Vandecruys, E | 1 |
| Benoit, Y | 1 |
| Philippet, P | 1 |
| Martelli, M | 1 |
| Baldi, I | 1 |
| Balzarotti, M | 1 |
| Bottelli, C | 1 |
| Conconi, A | 1 |
| Gomez, H | 1 |
| Lopez-Guillermo, A | 1 |
| Martinelli, G | 1 |
| Merli, F | 1 |
| Novero, D | 1 |
| Orsucci, L | 1 |
| Pavone, V | 1 |
| Ricardi, U | 1 |
| Storti, S | 1 |
| Gospodarowicz, MK | 1 |
| Cavalli, F | 2 |
| Sarris, AH | 2 |
| Fukuhara, S | 1 |
| Watanabe, T | 1 |
| Munakata, W | 1 |
| Mori, M | 1 |
| Maruyama, D | 1 |
| Kim, SW | 1 |
| Kobayashi, Y | 1 |
| Taniguchi, H | 1 |
| Maeshima, AM | 1 |
| Tanosaki, R | 1 |
| Matsuno, Y | 1 |
| Tobinai, K | 1 |
| Riley, JM | 1 |
| Russo, JK | 1 |
| Shipp, A | 1 |
| Alsharif, M | 1 |
| Jenrette, JM | 1 |
| Kaiser, U | 1 |
| Cavallin-Stahl, E | 2 |
| Haenel, M | 1 |
| Truemper, L | 1 |
| Vanderplas, A | 1 |
| LaCasce, AS | 1 |
| Rodriguez, MA | 2 |
| Crosby, AL | 1 |
| Lepisto, E | 1 |
| Czuczman, MS | 1 |
| Nademanee, A | 1 |
| Niland, J | 1 |
| Gordon, LI | 1 |
| Millenson, M | 1 |
| Friedberg, JW | 1 |
| Abel, GA | 1 |
| Armitage, JO | 2 |
| Miserocchi, E | 1 |
| Modorati, G | 1 |
| De Benedetto, U | 1 |
| Colucci, A | 1 |
| Bandello, F | 1 |
| Min, M | 1 |
| Lin, L | 1 |
| Bi, CF | 1 |
| Wang, XQ | 1 |
| Luo, TY | 1 |
| Zhao, S | 1 |
| Zhang, WY | 1 |
| Liu, WP | 1 |
| Guirguis, HR | 1 |
| Cheung, MC | 1 |
| Mahrous, M | 1 |
| Piliotis, E | 1 |
| Berinstein, N | 1 |
| Imrie, KR | 1 |
| Zhang, L | 1 |
| Buckstein, R | 1 |
| Yoon, JH | 1 |
| Kim, H | 1 |
| Lee, JW | 1 |
| Park, JD | 1 |
| Park, KD | 1 |
| Shin, HY | 1 |
| Ahn, HS | 1 |
| Holte, H | 2 |
| Leppä, S | 1 |
| Björkholm, M | 2 |
| Fluge, O | 1 |
| Jyrkkiö, S | 1 |
| Delabie, J | 1 |
| Sundström, C | 1 |
| Karjalainen-Lindsberg, ML | 1 |
| Erlanson, M | 1 |
| Kolstad, A | 1 |
| Fosså, A | 1 |
| Ostenstad, B | 1 |
| Löfvenberg, E | 1 |
| Nordström, M | 1 |
| Janes, R | 1 |
| Pedersen, LM | 1 |
| Anderson, H | 2 |
| Eriksson, M | 1 |
| Kobayashi, S | 1 |
| Sakurai, K | 1 |
| Tanikawa, M | 1 |
| Nishikawa, Y | 1 |
| Matsukawa, N | 1 |
| Okita, K | 1 |
| Fujiyoshi, Y | 1 |
| Shibamoto, Y | 1 |
| Mak, YK | 1 |
| Chan, CH | 1 |
| Li, CK | 1 |
| Lee, MP | 1 |
| Tsang, YW | 1 |
| Colović, M | 1 |
| Bogdanović, A | 1 |
| Janković, G | 1 |
| Kraguljac, N | 1 |
| Suvajdzić, N | 1 |
| Feugier, P | 1 |
| Virion, JM | 1 |
| Haioun, C | 1 |
| Marit, G | 1 |
| Macro, M | 1 |
| Bordessoule, D | 1 |
| Blanc, M | 1 |
| Lederlin, P | 1 |
| Harandi, A | 1 |
| Ghesani, M | 1 |
| Polosajian, L | 1 |
| Tupper, T | 1 |
| Sara, G | 1 |
| Hu, Y | 1 |
| Feng, FY | 1 |
| Shi, YK | 1 |
| Zhou, LQ | 1 |
| Gu, DZ | 1 |
| Wang, QL | 1 |
| Voss, N | 1 |
| Chhanabhai, M | 1 |
| Fairey, R | 1 |
| Hoskins, P | 1 |
| Morris, J | 1 |
| O'Reilly, SE | 1 |
| Pickles, T | 1 |
| Sehn, L | 1 |
| Derwich, K | 1 |
| Kaczmarek-Kanold, M | 1 |
| Wachowiak, J | 1 |
| Balcerska, A | 1 |
| Balwierz, W | 1 |
| Chybicka, A | 1 |
| Kowalczyk, JR | 1 |
| Matysiak, M | 1 |
| Sońta-Jakimczyk, D | 1 |
| Wysocki, M | 1 |
| Chełmecka-Hanuszewicz, L | 1 |
| Jackowska, T | 1 |
| Kołtan, A | 1 |
| Cwiklińska, M | 1 |
| Odój, T | 1 |
| Płoszyńska, A | 1 |
| Steczowicz, M | 1 |
| Wojciechowska, V | 1 |
| Wójtowicz, A | 1 |
| Yamanaka, R | 3 |
| Morii, K | 3 |
| Shinbo, Y | 3 |
| Takeuchi, S | 1 |
| Tamura, T | 3 |
| Hondoh, H | 3 |
| Onda, K | 2 |
| Tanaka, R | 3 |
| Marinković, M | 1 |
| Slavik, E | 1 |
| Janković, S | 1 |
| Cemerikic, V | 1 |
| Radulović, D | 1 |
| Tsao, CY | 1 |
| Lo, WD | 1 |
| Rusin, JA | 1 |
| Henwood, MJ | 1 |
| Boue, DR | 1 |
| Hagberg, H | 1 |
| Kvaloy, S | 1 |
| Teerenhovi, L | 1 |
| Myhre, J | 1 |
| Pertovaara, H | 1 |
| Ost, A | 1 |
| Nilsson, B | 1 |
| Osby, E | 1 |
| Chauvenet, AR | 1 |
| Martin, PL | 1 |
| Bell, BA | 1 |
| Kurtzberg, J | 1 |
| Pullen, J | 1 |
| Pettenati, MJ | 1 |
| Carroll, AJ | 1 |
| Shuster, JJ | 3 |
| Camitta, B | 1 |
| Sano, M | 2 |
| Homma, J | 2 |
| Tsuchiya, N | 2 |
| Yajima, N | 2 |
| Kunishio, K | 2 |
| Nagao, S | 1 |
| Gu, LJ | 1 |
| Li, J | 1 |
| Xue, HL | 1 |
| Tang, JY | 1 |
| Zhao, HJ | 1 |
| Ye, H | 1 |
| Pan, C | 1 |
| Kakuma, T | 1 |
| Cortes, J | 1 |
| O'Brien, SM | 1 |
| Pierce, S | 1 |
| Keating, MJ | 1 |
| Freireich, EJ | 1 |
| Kantarjian, HM | 2 |
| Mahoney, DH | 1 |
| Leventhal, BG | 1 |
| Civin, CJ | 1 |
| Ganick, DJ | 1 |
| Lauer, SJ | 1 |
| Steuber, CP | 1 |
| Kamen, BA | 1 |
| Chamberlain, MC | 2 |
| Colgan, JP | 2 |
| Andersen, J | 1 |
| Habermann, TM | 1 |
| Earle, JD | 2 |
| O'Connell, MJ | 1 |
| Neiman, RS | 1 |
| Mann, RB | 1 |
| Glick, JH | 1 |
| Lachance, DH | 1 |
| Brizel, DM | 1 |
| Gockerman, JP | 1 |
| Halperin, EC | 1 |
| Burger, PC | 1 |
| Boyko, OB | 1 |
| Brown, MT | 1 |
| Schold, SC | 1 |
| Lobo-Sanahuja, F | 1 |
| García, I | 1 |
| Barrantes, JC | 1 |
| Barrantes, M | 1 |
| Jiménez, R | 1 |
| Argüello, A | 1 |
| Beretta, F | 1 |
| Sanna, P | 1 |
| Ghielmini, M | 1 |
| Marini, G | 1 |
| Dent, S | 1 |
| Eapen, L | 1 |
| Girard, A | 1 |
| Hugenholtz, H | 1 |
| DaSilva, V | 1 |
| Stewart, DJ | 1 |
| Maeda, Y | 1 |
| Matsumoto, K | 1 |
| Kuriyama, M | 1 |
| Ono, Y | 1 |
| Tamiya, T | 1 |
| Furuta, T | 1 |
| Ohmoto, T | 1 |
| Kormanik, PA | 1 |
| Matsuda, M | 1 |
| Hattori, T | 1 |
| Tabata, K | 1 |
| Seki, S | 1 |
| Liow, K | 1 |
| Asmar, P | 1 |
| Liow, M | 1 |
| Spanaki, M | 1 |
| Townsend, JJ | 1 |
| Buys, S | 1 |
| Baringer, JR | 1 |
| Osborn, A | 1 |
| Gururangan, S | 1 |
| Sposto, R | 1 |
| Meadows, AT | 2 |
| Finlay, JL | 1 |
| Sklar, CA | 1 |
| Mertens, AC | 1 |
| Walter, A | 1 |
| Mitchell, D | 1 |
| Nesbit, ME | 1 |
| O'Leary, M | 1 |
| Hutchinson, R | 1 |
| Robison, LL | 1 |
| Garcia-Manero, G | 1 |
| O'Neill, BP | 1 |
| Wang, CH | 1 |
| O'Fallon, JR | 1 |
| Krigel, RL | 1 |
| Brown, LD | 1 |
| McGinnis, WJ | 1 |
| Visco, C | 1 |
| Mesina, OM | 1 |
| McLaughlin, P | 1 |
| Romaguera, JE | 1 |
| Cabanillas, F | 1 |
| Reni, M | 1 |
| Kochi, M | 1 |
| Ushio, Y | 1 |
| Falletta, JM | 1 |
| Crist, WM | 1 |
| Pullen, DJ | 1 |
| Wharam, M | 1 |
| Patterson, R | 1 |
| Foreman, E | 1 |
| Vietti, TJ | 1 |
| García Zueco, JC | 1 |
| Torres Gómez, M | 1 |
| López Gómez, L | 1 |
| Martín Guerrero, Y | 1 |
| Bashir, RM | 1 |
| Bierman, PJ | 1 |
| Vose, JM | 1 |
| Weisenburger, DD | 1 |
| Sweetenham, JW | 1 |
| Mead, GM | 1 |
| Whitehouse, JM | 1 |
| Schürmann, D | 1 |
| Dienemann, D | 1 |
| Jautzke, G | 1 |
| Cervos-Navarro, J | 1 |
| Langford, A | 1 |
| Stein, H | 1 |
| Pohle, HD | 1 |
| Ruf, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00180882] | Phase 3 | 260 participants | Interventional | 2004-10-31 | Recruiting | ||
| Biomarker Driven and Dose Intensified Chemoimmunotherapy With Early CNS Prophylaxis in Patients Less Than 65 Years With High Risk Diffuse Large B-Cell Lymphoma[NCT03293173] | Phase 2 | 120 participants (Anticipated) | Interventional | 2017-08-04 | Recruiting | ||
| CHOEP-14 + Rituximab With CNS Prophylaxis in Patients Less Than 65 Years With Diffuse Large B-Cell Lymphoma/Follicular Lymphoma Grade III, Stage II-IV With Risk Factors (Age Adjusted IPI) ≥ 2. A Phase II Study[NCT01502982] | Phase 2 | 160 participants (Actual) | Interventional | 2004-11-30 | Completed | ||
| NOURISH-T+: A Randomized Control Trial Targeting Parents in Promoting Healthy Eating and Exercise Behaviors in Pediatric Cancer Survivors With Overweight/Obesity[NCT04656496] | 520 participants (Anticipated) | Interventional | 2020-12-08 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
19 reviews available for prednisone and Central Nervous System Neoplasm
| Article | Year |
|---|---|
Central nervous system (CNS) prophylaxis in antiCD20-CHOP treated DLBCL at intermediate to high risk for CNS relapse: A systematic review and meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neopl | 2021 |
Prophylaxis strategies containing high dose intravenous methotrexate on preventing CNS relapse for patients with diffuse large B-cell lymphoma at intermediate to high risk: A study based on 12 cohorts in the rituximab era.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neopl | 2022 |
Central nervous system prophylaxis in diffuse large B-cell lymphoma: What does the evidence tell us?
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neopl | 2023 |
Efficacy of central nervous system prophylaxis with stand-alone intrathecal chemotherapy in diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy in the rituximab era: a systematic review.
Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nerv | 2020 |
Current progress and future perspectives of research on intravascular large B-cell lymphoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Cell | 2021 |
How to Decide Which DLBCL Patients Should Receive CNS Prophylaxis.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2018 |
Central Nervous System Prophylaxis Strategies in Diffuse Large B Cell Lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nerv | 2018 |
Optimizing initial therapy in DLBCL.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nerv | 2018 |
Impact of rituximab on incidence of and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2014 |
Prophylactic CNS directed therapy in systemic diffuse large B cell lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nerv | 2014 |
Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) after treatment for Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Central Nervous System Neoplasms; Chr | 2015 |
Primary renal diffuse large B-cell lymphoma with central nervous system involvement: a rare case report and literature review.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Prot | 2015 |
Extranodal lymphoma: a reappraisal.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy P | 2008 |
Contralateral testicular relapse after prophylactic radiation in a patient with primary testicular diffuse large B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2009 |
Intrathecal chemotherapy in lymphomatous meningitis.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nerv | 2011 |
Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chem | 2012 |
The hyper-CVAD regimen in adult acute lymphocytic leukemia.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Antibodies, Monoclonal; Anti | 2000 |
Therapeutic management of refractory or relapsed primary central nervous system lymphomas.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous Sys | 2001 |
[Chemo-radiotherapy for malignant brain tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Central Nervous System | 2002 |
23 trials available for prednisone and Central Nervous System Neoplasm
| Article | Year |
|---|---|
Impact of central nervous system (CNS) prophylaxis on the incidence of CNS relapse in patients with high-risk diffuse large B cell/follicular grade 3B lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous Syst | 2020 |
Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nerv | 2017 |
CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): analysis from two phase 2 studies.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherap | 2018 |
Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report.
Topics: Adolescent; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2014 |
Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab era.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic C | 2015 |
Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow Neoplasm | 2016 |
Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Central Ne | 2008 |
The impact of acute lymphoblastic leukemia treatment on central nervous system results in Bogota, Colombia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; | 2008 |
First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2011 |
Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agent | 2013 |
Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agent | 2013 |
Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agent | 2013 |
Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agent | 2013 |
Long-term survival in acute lymphoblastic leukaemia in adults treated according to the LALA 87 protocol.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Pro | 2003 |
Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cohort Studi | 2007 |
Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Cell Lineage; Central N | 2007 |
Salvage therapy and late neurotoxicity in patients with recurrent primary CNS lymphoma treated with a modified ProMACE-MOPP hybrid regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combi | 2007 |
Clinical outcome of children with newly diagnosed acute lymphoblastic leukemia treated in a single center in Shanghai, China.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System Neo | 2008 |
Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; C | 1995 |
Long-term follow-up of a CHOP-based regimen with maintenance therapy and central nervous system prophylaxis in lymphoblastic non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous Sys | 1994 |
Stage III abdominal non-Hodgkin's lymphoma in Costa Rican children: comparison of two consecutive trials of treatment.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasm | 1994 |
PROMACE-MOPP and intrathecal chemotherapy for CNS lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclo | 1996 |
Outcome of CNS disease at diagnosis in disseminated small noncleaved-cell lymphoma and B-cell leukemia: a Children's Cancer Group study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; | 2000 |
Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Body Height; Body Mass Inde | 2000 |
The consequences of treatment and disease in patients with primary CNS non-Hodgkin's lymphoma: cognitive function and performance status. North Central Cancer Treatment Group.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neo | 1999 |
Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous Sys | 1992 |
81 other studies available for prednisone and Central Nervous System Neoplasm
| Article | Year |
|---|---|
Rituximab, Methotrexate, Carmustine, Etoposide, and Prednisone (RMBVP) for the treatment of relapsed/refractory primary central nervous system lymphoma: a retrospective single-center study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System; Central Ne | 2022 |
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophospha | 2022 |
About time: why central nervous system prophylaxis timing in diffuse large B-cell lymphoma matters and does the protocol need updating?
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neopl | 2022 |
[Risk assessment and prophylactic treatment strategies for central nervous system relapse of diffuse large B-cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neopl | 2023 |
Asian variant of intravascular large B-cell lymphoma: a comparison of clinical features based on involvement of the central nervous system.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neopl | 2020 |
Clinical Effect of CD25 on the Prognosis of Diffuse Large B Cell Lymphoma with Secondary Central Nervous System Relapse.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; C | 2020 |
Central Nervous System International Prognostic Index Impacts Overall Survival in Diffuse Large B-cell Lymphoma Treated with R-Chop in a third Level Cancer Center from Mexico: A Survey of 642 Patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous | 2021 |
R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvement.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neop | 2022 |
Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous Syst | 2021 |
[Current achievements and future perspectives in the research on intravascular large B-cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; | 2021 |
Impact of Initial CSF Findings on Outcome Among Patients With National Cancer Institute Standard- and High-Risk B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System Neoplasms; Cere | 2017 |
The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic C | 2018 |
Frequency, risk factors, and outcomes of central nervous system relapse in lymphoma patients treated with dose-adjusted EPOCH plus rituximab.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarke | 2017 |
Tubulointerstitial capillaries limited intravascular lymphoma of the kidney.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antigens, CD; Antineoplastic Combined Chemotherapy Pro | 2017 |
Primary central nervous system lymphoma: Retrospective analysis of 34 cases in a single centre.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child | 2018 |
Central nervous system lymphoma in 18 dogs (2001 to 2015).
Topics: Animals; Anti-Inflammatory Agents; Central Nervous System Neoplasms; Decompression, Surgical; Dog Di | 2018 |
Addition of high-dose methotrexate to standard treatment for patients with high-risk diffuse large B-cell lymphoma contributes to improved freedom from progression and survival but does not prevent central nervous system relapse.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclo | 2019 |
Successful use of an immune checkpoint inhibitor in a patient with myasthenia gravis in remission.
Topics: Antineoplastic Agents, Immunological; Azathioprine; Central Nervous System Neoplasms; Cholinesterase | 2019 |
[A case of secondary central nervous system lymphoma presenting marked hypoglycorrhachia].
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomar | 2019 |
Stand-alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R-CHOP and is associated increased infection-related toxicity.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neop | 2019 |
Secondary central nervous system involvement in 599 patients with diffuse large B-cell lymphoma: are there any changes in the rituximab era?
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined | 2013 |
Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG).
Topics: Anti-HIV Agents; Antibiotic Prophylaxis; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Comb | 2014 |
Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central | 2015 |
A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma.
Topics: Acute Kidney Injury; Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Antibo | 2014 |
Rituximab plus a CHOP-like regimen, central nervous system prophylaxis, and contralateral testicular irradiation for localized primary testicular diffuse large B-cell lymphoma lead to prolonged progression-free survival.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherap | 2014 |
Management and prognosis of 66 patients with B-cell non-Hodgkin lymphoma presenting with initial spinal cord compression: a French retrospective multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Centr | 2015 |
Central nervous system relapse in peripheral T-cell lymphomas: a Swedish Lymphoma Registry study.
Topics: Adult; Aged; Aged, 80 and over; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Combi | 2015 |
A Demyelinating Disease; What Lies Beneath?
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System Neoplasms; Child, Pres | 2016 |
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Burkitt Lymphoma; Central Ner | 2016 |
Progressive outer retinal necrosis syndrome in the course of systemic lupus erythematosus.
Topics: Adult; Antiviral Agents; Central Nervous System Neoplasms; Chloroquine; Chorioretinitis; Fatal Outco | 2016 |
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic C | 2016 |
Site of central nervous system (CNS) relapse in patients with diffuse large B-cell lymphoma (DLBCL) by the CNS-IPI risk model.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cent | 2017 |
Dose-Adjusted EPOCH-R and Mid-Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondary CNS Involvement.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality | 2017 |
Durable clinical remission induced by romidepsin for chemotherapy-refractory peripheral T-cell lymphoma with central nervous system involvement.
Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemoth | 2017 |
New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central | 2016 |
Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous Syst | 2016 |
Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; British Columbia; Ce | 2017 |
The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: An international multicenter study of 1532 patients treated with chemoimmunotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic C | 2017 |
Treatment of initial parenchymal central nervous system involvement in systemic aggressive B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2017 |
Unilateral facial nerve palsy as an early presenting symptom of relapse in a paediatric patient with acute lymphoblastic leukaemia.
Topics: Acyclovir; Adolescent; Antiviral Agents; Bell Palsy; Central Nervous System Neoplasms; Facial Nerve; | 2017 |
[Therapeutic management of central nervous system lymphomas in a single hematological institute].
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined | 2009 |
Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2010 |
Central nervous system involvement in diffuse large B-cell lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2010 |
Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined | 2010 |
Elevated LDH and paranasal sinus involvement are risk factors for central nervous system involvement in patients with peripheral T-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central | 2011 |
Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2011 |
Second neoplasm in children treated in EORTC 58881 trial for acute lymphoblastic malignancies: low incidence of CNS tumours.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System Neo | 2011 |
How I treat primary CNS lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2011 |
Bulky disease has an impact on outcomes in primary diffuse large B-cell lymphoma of the breast: a retrospective analysis at a single institution.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Central Nervous Syste | 2011 |
Central nervous system myelomatosis with optic neuropathy and intramedullary spinal cord compression responding to radiation therapy.
Topics: Central Nervous System Neoplasms; Dexamethasone; Female; Glucocorticoids; Humans; Magnetic Resonance | 2011 |
CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group.
Topics: Adolescent; Adult; Age of Onset; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Che | 2012 |
Lack of benefit of central nervous system prophylaxis for diffuse large B-cell lymphoma in the rituximab era: findings from a large national database.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nerv | 2012 |
My treatment approach to patients with diffuse large B-cell lymphoma.
Topics: Adult; Aged; Algorithms; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cen | 2012 |
Birdshot retinochoroidopathy masquerading as intraocular lymphoma.
Topics: Adult; Antigens, CD19; Antigens, CD20; Birdshot Chorioretinopathy; Central Nervous System Neoplasms; | 2012 |
[Analysis of the immunohistochemical subtypes and prognosis of primary diffuse large B cell lymphoma of the central nervous system].
Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemot | 2012 |
Successful treatment of primary central nervous system lymphoma without irradiation in children: single center experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; | 2012 |
A case of central nervous system lymphoma manifesting as multiple patchy white matter lesions with a past history of tonsil lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; | 2012 |
Clinical profiles of human immunodeficiency virus-associated lymphoma in Hong Kong.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Ac | 2003 |
Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2004 |
Value of positron emission tomography scan in staging cancers, and an unusual presentation of acute myeloid leukemia. Case 1. Demonstration of CNS lymphoma by positron emission tomography scan affects management.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System | 2004 |
[Primary central nervous system lymphoma: a report of 28 patients].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neop | 2004 |
The treatment of primary central nervous system lymphoma in 122 immunocompetent patients: a population-based study of successively treated cohorts from the British Colombia Cancer Agency.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cohor | 2005 |
[Treatment results in children with standard-risk acute lymphoblastic leukemia. Report of the Polish Pediatric Leukemia/Lymphoma Study Group].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Neoplasm | 2004 |
Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Centra | 2005 |
Extranodal marginal zone B-cell lymphoma most probably of MALT type appearing in CNS as parasagittal extracerebral tumor.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2006 |
Isolated neurosarcoidosis presenting as headache and multiple brain and spinal cord lesions mimicking central nervous system metastases.
Topics: Adolescent; Anti-Inflammatory Agents; Brain; Central Nervous System Diseases; Central Nervous System | 2007 |
Prognostic implication of p27 expression in primary central nervous system lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Nuc | 2006 |
Results of treatment of 112 cases of primary CNS lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous Syst | 2008 |
The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Combined Chemotherapy Protocol | 1995 |
CNS lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; | 1995 |
Cyclophosphamide, doxorubicin, vincristine, and prednisone for primary central nervous system lymphoma: short-duration response and multifocal intracerebral recurrence preceding radiotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophospha | 1994 |
[Paraplegia following intrathecal chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cisplatin; | 1996 |
[Clinical study of primary central nervous system lymphoma: the role of chemotherapy].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neop | 1997 |
AIDS-related central nervous system lymphomas.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neopl | 1999 |
[A case of non-Hodgkin lymphoma in the central nervous system, developing during treatment of galactorrhea amenorrhea syndrome].
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; | 1999 |
Intravascular lymphomatosis: contribution of cerebral MRI findings to diagnosis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System Neoplasms; Cyclo | 2000 |
Non-Hodgkin's lymphoma affecting the testis: is it curable with doxorubicin-based therapy?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclo | 2001 |
[Late recurrence (11 years) in a case of ALL. Recurrence or a second disease?].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System Neo | 1992 |
Central nervous system involvement in patients with diffuse aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 1991 |
Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Neopl | 1991 |
Malignant lymphomas in HIV-seropositive patients. Frequency, features, and prognosis. Report on 31 cases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Neoplasms; | 1991 |